DWTX Stock Summary and Trading Ideas (Dogwood Therapeutics | NASDAQ:DWTX)

Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.

Dogwood Therapeutics trades on the NASDAQ stock market under the symbol DWTX.

As of April 23, 2026, DWTX stock price declined to $1.40 with 160,632 million shares trading.

DWTX has a beta of 0.45, meaning it tends to be less sensitive to market movements. DWTX has a correlation of 0.00 to the broad based SPY ETF.

DWTX has a market cap of $46.76 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that DWTX belongs to (by Net Assets): VXF.

DWTX has underperformed the market in the last year with a price return of -74.4% while the SPY ETF gained +35.8%. DWTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -54.4% and -27.8%, respectively, while the SPY returned +3.1% and +4.8%, respectively.

DWTX support price is $1.39 and resistance is $1.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DWTX shares will trade within this expected range on the day.